BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3150012)

  • 21. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma.
    Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N
    Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.
    Tsukaguchi K; de Lange B; Boom WH
    Cell Immunol; 1999 May; 194(1):12-20. PubMed ID: 10357876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
    Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.
    Debs RJ; Fuchs HJ; Philip R; Montgomery AB; Brunette EN; Liggitt D; Patton JS; Shellito JE
    J Immunol; 1988 May; 140(10):3482-8. PubMed ID: 3283235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induction of tumor necrosis factor (TNF) by OK-432].
    Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
    Gan No Rinsho; 1984 Aug; 30(10):1290-2. PubMed ID: 6481965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432.
    Kimura S; Inoue T; Yamashita T; Midorikawa Y; Arai S; Sendo F
    Cancer Res; 1987 Dec; 47(23):6204-9. PubMed ID: 3315182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
    Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
    Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [OK 432-induced production of IFN-gamma in peripheral mononuclear cells from healthy subjects and patients with cancer].
    Matsumoto H; Izutani R; Terada M; Noguchi J; Shiraha S; Kuyama T; Aoki N
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):751-8. PubMed ID: 2506311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H; Oshima H; Soma G; Mizuno D
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
    Mori H; Itoh N; Shiraki S; Tamaya T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
    [No Abstract]   [Full Text] [Related]  

  • 38. IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression.
    Hermann P; Rubio M; Nakajima T; Delespesse G; Sarfati M
    J Immunol; 1998 Aug; 161(4):2011-8. PubMed ID: 9712074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
    Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Nishii Y; Suzuki S; Watanabe N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
    Fujimoto T; Duda RB; Szilvasi A; Chen X; Mai M; O'Donnell MA
    J Immunol; 1997 Jun; 158(12):5619-26. PubMed ID: 9190909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.